10.1002/jnr.23749 http://scihub22266oqcxt.onion/10.1002/jnr.23749 C5074285!5074285
!27112131
free free free
Warning : file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27112131
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
J+Neurosci+Res
2016 ; 94
(8
): 693-701
Nephropedia Template TP gab.com Text Twit Text FOAVip Twit Text # English Wikipedia
Role of regulatory b cells in neuroimmunologic disorders
#MMPMID27112131
Han J
; Sun L
; Fan X
; Wang Z
; Cheng Y
; Zhu J
; Jin T
J Neurosci Res
2016[Aug]; 94
(8
): 693-701
PMID27112131
show ga
B lymphocytes augment the immune response by producing antibodies and activating
T cells by antigen presentation. Recent studies have highlighted a specific and
functionally significant B-cell subset that could downregulate excessive immune
and inflammatory responses through a vast array of inhibitory cytokines, such as
interleukin (IL)-10 and transforming growth factor-? (TGF-?). This subset of B
cells is generally referred to as regulatory B cells (Bregs). In addition, recent
studies have shown that IL-35-producing Bregs also play a role in downregulation
of immunity. Diverse phenotypes of Bregs have been proposed to underlie human
disorders and their animal models. Most studies have focused on the role of
different subsets of Bregs and Bregs-associated molecules such as IL-10, TGF-?,
and IL-35 in the pathogenesis of neuroimmunologic disorders. Furthermore, Bregs
exert regulatory function mainly through suppressing the differentiation of
Th1/Th17 cells and promoting regulatory T-cell expansion. Reduced presence of
Bregs is reportedly associated with progression of several neuroimmunologic
disorders. This Review summarizes the current knowledge on the role of Bregs in
neuroimmunologic disorders, including multiple sclerosis, neuromyelitis optica,
and myasthenia gravis. © 2016 The Authors. Journal of Neuroscience Research
Published by Wiley Periodicals, Inc.
Please enable JavaScript to view the comments powered by Disqus. |*B-Lymphocytes, Regulatory
[MESH] |*Neuroimmunomodulation
[MESH] |Animals
[MESH] |Humans
[MESH] DeepDyve Pubget Overpricing